The blood-brain barrier (BBB) is composed mainly of specialized endothelial cells characterized by the presence of intercellular tight junctions. Additionally, perivascular cells, astrocytes, and surrounding basement membranes determine BBB integrity. BBB disruption is an early phenomenon in the formation of new white matter multiple sclerosis (MS) lesions; however, knowledge of the extent of BBB changes in gray matter MS lesions is lacking. Here, we studied several markers for BBB integrity in wellcharacterized brain tissue of patients with MS. Plasma protein leakage was enhanced in white matter lesions compared with that in normal-appearing white matter, whereas plasma protein leakage was absent in gray matter lesions. White matter lesions showed irregular basement membranes and parenchymal depositions of collagen type IV, whereas purely gray matter lesions lacked basement membrane alterations. Similarly, we observed no evidence for astrogliosis and tight junction changes in cortical MS lesions. Although BBB dysfunction is a common feature of white matter MS lesions, cortical MS lesions lack markers for BBB disruption or astrogliosis. Our data may indicate that BBB breakdown is not a critical event in the formation of gray matter MS lesions.
INTRODUCTION
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). Although the cause of MS is unknown, environmental factors and genetic susceptibility have been implicated in the development of the disease. MS lesions occur in all brain areas, although there are several predilection sites, including subcortical white matter, optic nerves, periventricular white matter, brainstem, and cervical spinal cord (1) . MS white matter lesions are histopathologically characterized by infiltration of leukocytes, predominantly monocyte-derived macrophages, into the CNS, distinct areas of demyelination, and axonal damage and loss (2) .
The blood brain-barrier (BBB) is a selective barrier that protects the CNS microenvironment from the systemic circulation by limiting transport of immune cells and molecules into the brain parenchyma (3, 4) . The BBB is formed by highly specialized endothelial cells with intercellular tight junction complexes, perivascular cells, astrocyte end feet, and two distinct basement membranes. Brain endothelial cells are enclosed by a vascular basement membrane, whereas the astroglial basement membrane covers perivascular cells and is formed mainly by astrocytes (5) . Evidence is emerging that BBB breakdown is an early and critical step in white matter lesion development (6) .
Damage to the BBB in white matter MS lesions has been demonstrated in patients by magnetic resonance imaging using gadolinium enhancement (7Y10). In addition, immunohistochemical studies on postmortem tissue of patients with MS demonstrated increased leakage of plasma proteins (6, 11Y13), tight junction changes (14, 15) , basement membrane alterations (3, 16) , and increased numbers of astrocyte processes (17, 18) . Collectively, these studies show that BBB damage is extensive in white matter MS lesions.
The occurrence of gray matter MS lesions has been largely underestimated until recently. To date, evidence that extensive demyelination occurs in the cerebral cortex of patients with chronic MS has been accumulating (19Y22); however, little is known about potential BBB dysfunctioning in cortical MS lesions. In this study, we have analyzed plasma protein leakage, basement membrane, and tight junction morphology and astrocytic changes in well-characterized cortical MS lesions and nonlesional gray matter areas to characterize the presence and extent of BBB damage in cortical MS lesions. Although BBB dysfunctioning is a common feature of white matter MS lesions, surprisingly we found no immunohistologic evidence for BBB disruption or astrogliosis in purely cortical MS lesions. This may suggest that other mechanisms underlie gray matter lesion formation. autopsy and immediately frozen in liquid nitrogen (in collaboration with The Netherlands Brain Bank, coordinator Dr. Ravid). Five cases without neurologic disease were selected as controls. White matter MS tissue samples were selected using postmortem magnetic resonance imaging as published previously (9, 10) . Cortical lesions were detected by immunohistochemical analysis using an antibody against myelin-specific proteolipid protein. The mean ages of the patients and control subjects were 52.6 and 55.2 years, respectively. Additional relevant clinical information was retrieved from the medical records and is summarized in Table 1 . All patients and control subjects or their next of kin had given informed consent for autopsy and use of their brain tissue for research purposes.
Lesion Classification
Classification of the lesions was based on standard histopathologic stainings for myelin (proteolipid protein [PLP] and inflammatory cells [LN3: anti-major histocompatibility complex class II]) as described previously (23Y25). Active lesions are characterized by abundant phagocytic perivascular and parenchymal macrophage infiltration throughout the lesion area, whereas chronic active lesions have a demyelinated gliotic center with a hypercellular rim containing macrophages. Chronic inactive lesions have few infiltrating inflammatory cells throughout the lesion. Cortical gray matter lesions were classified according to their location in the cerebral cortex as either intracortical or combined gray matter/white matter lesions. This classification corresponds to Type IIYIV and Type I in the gray matter lesion classification previously published by us (20) . Based on the abovementioned classification, we identified 12 purely gray matter lesions from 7 patients, 24 combined gray matter/white matter lesions (Type I) from 11 patients, 41 (chronic) active white matter lesions from 16 patients, and 3 chronic inactive white matter lesions from 3 patients. All purely cortical lesions extended inward from the surface of the brain (Type III) (26) .
Immunohistochemistry
For immunohistochemical staining, 5-Km cryosections were air-dried and fixed in acetone for 10 minutes. Next, sections were preincubated with normal serum (swine serum 1:10 or rabbit serum 1:50 diluted in 1% bovine serum albumin in PBS, pH 7.4, for 10 minutes). Then, sections were incubated for 60 minutes with the appropriate primary antibody and subsequently incubated with a biotinylated swine-anti-rabbit F(ab') 2 (1:300, DakoCytomation, Glostrup, Denmark) or a biotinylated rabbit-anti-mouse F(ab_) 2 (1:500, Dako) for 30 minutes. After incubating for 60 minutes with Table 2 .
Quantification of Serum Protein Leakage
Intensity of immunostaining was measured by light transmittance on digital images of fibrinogen and IgG immunostained sections using the computer program Scion Image. Mean density of staining in the lesion and nonlesion area within the same tissue block was measured using an arbitrary scale from 0 to 255. High-density values correspond to little plasma protein leakage due to increased light transmittance, whereas severe plasma protein leakage corresponds to decreased light transmittance and thus low-density values. Total lesion areas were analyzed, whereas the nonlesion areas with the lowest extent of microglial activation within the same tissue block were selected for study in nonlesion white matter. In normal-appearing gray matter (NAGM), an area of the same size, spanning the same cortical layers at a maximal distance to the lesion, was selected. Mean density values were then graphically visualized in a boxplot. 
Statistical Analysis
The Mann-Whitney U test was performed on the BBB leakage indices described previously. All statistical analyses were performed two-tailed with a confidence level of 95%.
RESULTS

IgG and Fibrinogen Leakage
Fibrinogen and IgG immunoreactivity was detected within blood vessel lumens, blood vessels walls in NAGM and normal-appearing white matter (NAWM), whereas in white matter lesions fibrinogen and IgG staining was observed in the parenchyma as well as in astrocyte cell bodies and processes. Additionally, we observed weak fibrinogen expression in the parenchyma directly adjacent to large blood vessels in the NAWM. Fibrinogen and IgG immunoreactivity in gray matter lesions as well as in NAGM was restricted to the lumen and wall of cerebral blood vessels (Fig. 1AYD ). In the gray matter part of combined white matter/gray matter lesions, we occasionally observed immunopositivity on astrocytes and blood vessels (data not shown). Statistical analysis demonstrated that in white matter lesions and the white matter part of type I lesions, immunoreactivity for fibrinogen and IgG was increased compared with that in NAWM (fibrinogen: p G 0.05, IgG: p G 0.05). No significant increase of fibrinogen or IgG immunostaining was found in intracortical gray matter lesions (fibrinogen: p = 0.25, IgG: p = 0.86) and the gray matter part of type I lesions (fibrinogen: p = 0.41, IgG: p = 0.36) compared with NAGM (Fig. 2) . It is possible that small focal areas of protein leakage within gray matter lesions would not be detected by whole lesion optical density measurements. By qualitative light microscopical evaluation, focal intracortical areas of IgG or fibrinogen leakage were not detected, however.
Basement Membrane Morphology
To study basement membrane changes we used an antibody directed against collagen type IV, a major component of basement membranes (Fig. 3) . White matter lesions and the white matter part of Type I lesions (Fig. 3A) frequently contained discontinuous basement membranes and parenchymal depositions of collagen type IV (Fig. 3D, E) . Further, we observed widened Virchow-Robin spaces due to leukocyte accumulation (Fig. 3D) , which was rarely seen in the gray matter part of combined lesions (2 of 24 lesions, data not shown). In contrast, no basement membrane changes were observed in gray matter lesions (Fig. 3G) , in which the pattern of collagen type IV immunopositivity was indistinguishable from in nondemyelinated control areas (Fig. 3F) .
Glial Fibrillary Acidic Protein Expression
In purely gray matter lesions the extent and distribution of glial fibrillary acidic protein (GFAP) immunopositivity on blood vessel, astrocyte processes, and cell bodies were similar to those in NAGM in the same tissue block (Fig. 4AYC) and to cerebral cortex in non-neurologic controls. In all types of white matter lesions, increased GFAP immunopositivity on astrocyte processes was detected compared with normal white matter, whereas, in general, astrocyte cell bodies displayed higher levels of GFAP immunopositivity at the edge of white matter lesions (Fig. 4D, E) . Sporadically, we observed a slight increase in GFAP immunostaining in the gray matter part of combined gray matter/white matter lesions compared with nondemyelinated gray matter.
Tight Junction Morphology
To study the distribution of tight junctions in white and gray matter MS lesions we used a well-characterized white matter MS lesions. These findings are in line with previous reports, demonstrating that BBB breakdown is a characteristic of white matter MS lesions (6, 11Y13). We observed subtle changes in the gray matter part of combined gray matter/white matter lesions, such as a slight increase in GFAP immunoreactivity, indicative of astrogliosis. These findings were not observed in pure gray matter lesions or in nondemyelinated MS gray matter. BBB breakdown was thus not detected by any of the measures of BBB integrity used in this study, indicating that the BBB is relatively preserved in pure gray matter lesions. However, we cannot exclude the presence of minor ultrastructural changes in the gray matter BBB that are not detectable by the methods used here.
Our findings indicate that BBB disruption is not a necessary event for demyelination to occur in the gray matter. Alternatively, BBB damage in the gray matter may only occur in the actively demyelinating phase. It is not possible at present to determine the age and activity level of purely cortical lesions; it is thus possible that all intracortical lesions studied in this material were inactive. The (relative) absence of BBB damage in the gray matter corresponds well with the results of magnetic resonance imaging studies, as gadoliniumenhancement is rarely observed in gray matter lesions using normal dosing of gadolinium-diethylenetriamine pentaacetic acid. Gray matter enhancement can be increased by increasing gadolinium doses, indicating that there may be low-grade BBB damage in gray matter also (27, 28) . If purely cortical lesions had conveyed significant BBB alterations, these would thus be expected to be visible as areas of contrast enhancement in otherwise normal-appearing MS gray matter and to our knowledge this has not been observed so far. Demyelinating lesions do occur in gray matter without BBB changes, indicating that BBB damage is not a primary or necessary event in the formation of purely gray matter lesions. This finding would be consistent with recent hypotheses of a role for primary oligodendrocyte degeneration in (a proportion of) MS patients (29) .
The observation that serum protein leakage persists in white matter MS lesions and is consistent with earlier studies (11Y13). Previously, we demonstrated extravascular distribution of fibrinogen (6), indicating BBB disturbance, throughout the parenchyma of all white matter lesion types. In highly active white matter lesions, serum protein deposition was predominantly observed around blood vessels in a fibrillar-like fashion and less extensively in the parenchyma. In chronic lesions, fibrinogen and IgG staining was detected throughout the lesion area and colocalized with astrocyte processes. In contrast to white matter MS lesions, we observed no significant serum protein leakage in gray matter lesions.
Leukocytes frequently accumulate within the perivascular space in white matter lesions, which is lined by a vascular basement membrane and a parenchymal or astroglial basement membrane. Both basement membranes consist of characteristic sheet-like structures of extracellular matrix molecules comprising laminin, heparan sulfate proteoglycans, and collagen type IV. As reported previously, we observed a clear widening of the Virchow-Robin space in chronic active and active white matter MS lesions. Additionally, we found collagen type IV-immunoreactive
